Effect of sirolimus withdrawal in patients with deteriorating renal function (Q45058867)

9 December 2017

Effect of sirolimus withdrawal in patients with deteriorating renal function (English)

1 reference

9 December 2017

1 reference

Bruce Kaplan

1

1 reference

9 December 2017

Jesse Schold

2

1 reference

9 December 2017

Titte Srinivas

3

1 reference

9 December 2017

Karl Womer

4

1 reference

9 December 2017

David P Foley

5

1 reference

9 December 2017

Pamela Patton

6

1 reference

9 December 2017

Richard Howard

7

1 reference

9 December 2017

Herwig-Ulf Meier-Kriesche

8

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

American Journal of Transplantation

9 December 2017

1 reference

9 December 2017

4

1 reference

9 December 2017

10

1 reference

9 December 2017

1709-1712

1 reference

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

9 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

Median effect analysis of efficacy versus adverse effects of immunosuppressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

The natural history of chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00569.X

10.1111/J.1600-6143.2004.00569.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference